Bright Minds Biosciences ...

NASDAQ: DRUG · Real-Time Price · USD
41.80
-0.74 (-1.74%)
At close: Aug 15, 2025, 3:59 PM
41.12
-1.64%
After-hours: Aug 15, 2025, 07:59 PM EDT

Bright Minds Biosciences Cash Flow Statement

Financials in CAD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-2.95M 49.61K -773.44K 229.9K -574.14K -1.68M -1.53M -1.46M -2.05M -2.34M -2.96M -2.66M -4.49M -4.86M -2.87M -3.53M -1.5M -753.42K
Depreciation & Amortization
22.48K 21.53K 19.02K 18.11K 18.11K 18.11K 18.11K 18.11K 18.11K 18.11K 6.04K n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
615.91K 176.39K 210.24K 183.94K 226.64K 218.95K 400.5K 237.53K 29.96K 484.14K 29.91K 293.38K 290.83K 260.93K 376.56K 260.8K 6.84K 236.41K
Other Working Capital
27.92K -101.76K 93.39K -153.43K 28.22K 587.91K -322.05K -251.69K 458.67K -934.05K 937.27K -613.32K 570.92K -122.92K 285.28K 48.39K 176.92K 18.21
Other Non-Cash Items
25.34K -1.62M -12.37K -38.36K 775.37K 2.97K 3.79K 4.58K 2M 7.05K -43.42K 4.28K 6.99K -191.38K -152.29K 293.25K 3.8K -8.68
Deferred Income Tax
n/a n/a n/a n/a n/a 42.3K 163.44K -130.47K n/a n/a -6.04K n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-138.63K -118.56K 93.39K -153.43K -479.99K 579.85K -255.36K -322K 484.58K -837.55K 845.93K -501.36K 544.2K -162.47K 253.12K 6.67K 140.67K -94.37K
Operating Cash Flow
-2.43M -1.49M -463.17K 240.16K -805.09K -822.09K -1.2M -1.65M 484.58K -2.66M -2.13M -2.86M -3.65M -4.95M -2.39M -2.97M -1.35M -611.37K
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 22.88 -22.88
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a -11.19M n/a n/a n/a n/a n/a n/a n/a 22.88 -22.88
Debt Repayment
-24.63K -23.79K -23.86K -21.96K -21.96K -21.96K -21.64K -21.49K -21.49K -21.49K 24.84K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.7 n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
250.01K 3.44M 302.00 n/a n/a n/a n/a n/a n/a 1.06M 1M 12K 1.68K 118.25K -9.7K -545.55K -1.2M 22.88K
Financial Cash Flow
225.38K 52.04M -23.56K -21.96K -21.96K 878.04K -21.64K -21.49K -21.49K 2.25M 5.06M 12K 1.68K 118.25K -9.7K -545.55K 24.73M 1.88M
Net Cash Flow
-2.22M 52.18M -470.15K 257.81K -829.21K 13.66K -1.38M -1.54M -10.73M -416.41K 2.99M -2.83M -3.65M -4.64M -2.25M -3.44M 23.39M 1.26M
Free Cash Flow
-2.43M -1.49M -463.17K 240.16K -805.09K -822.09K -1.2M -1.65M 484.58K -2.66M -2.13M -2.86M -3.65M -4.95M -2.39M -2.97M -1.35M -611.37K